Literature DB >> 32301225

Early worsening of diabetic retinopathy after simultaneous pancreas and kidney transplantation-Myth or reality?

Barbora Voglová1,2, Zuzana Hladíková1,2, Lenka Nemétová1, Martina Zahradnická1, Kateřina Kesslerová3, Tomáš Sosna3, Květoslav Lipár4, Radomíra Kožnarová1, Peter Girman1, František Saudek1.   

Abstract

Early worsening of diabetic retinopathy due to sudden glucose normalization is a feared complication of pancreas transplantation; however, its rate or severity has not been studied prospectively. We followed up 43 pancreas and kidney recipients for a composite endpoint comprising new need for laser therapy, newly diagnosed proliferation, macular edema, visual acuity worsening, and blindness over 12 months. Although 37% of patients met this primary endpoint, its severity was rather low. Mean central retinal thickness and proportion of patients with subclinical macular edema increased significantly, with spontaneous resolution in half of them. Visual acuity did not change. There was no significant difference in the absolute glycated hemoglobin (HbA1c) drop, age, and diabetes duration between the patients who met and those who did not meet the primary endpoint, but a higher proportion of patients with worsening had a recent history of laser treatment. Retinopathy remained stable in 62.8% of patients. In 26%, the visual acuity significantly improved. Although retinopathy worsening was documented in more than one-third of patients, its evolution was not related to the magnitude of metabolic change; rather, it corresponded to the expected natural course of retinopathy. Nonetheless, comprehensive ophthalmologic care should be a substantial component of the recipient management.
© 2020 The American Society of Transplantation and the American Society of Transplant Surgeons.

Entities:  

Keywords:  clinical research/practice; diabetes: secondary complications; diabetes: type 1; endocrinology/diabetology; immunosuppressant; pancreas/simultaneous pancreas-kidney transplantation

Mesh:

Substances:

Year:  2020        PMID: 32301225     DOI: 10.1111/ajt.15924

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  1 in total

1.  Diabetic Retinopathy and Insulin Insufficiency: Beta Cell Replacement as a Strategy to Prevent Blindness.

Authors:  Eli Ipp
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-29       Impact factor: 6.055

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.